---
schema_version: "secwatch.filing_event.v1"
accession: "0001367644-24-000158"
form_type: "8-K"
ticker: "EBS"
cik: "0001367644"
company_name: "Emergent BioSolutions Inc."
filed_at: "2024-09-17T23:59:59+00:00"
generated_at: "2026-05-31T04:13:27.585008+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Emergent BioSolutions issues 1.1M shares to lenders, sets warrant exercise prices at $9.88 and $15.72

## Summary
- Issued 1,113,338 shares of common stock at ~$8.98 per share to lenders under Term Loan Agreement.
- Series I Warrants for 1M shares at $9.8802 exercise price; Series II Warrants for 1.5M shares at $15.7185.
- No proceeds from share issuance; company will receive proceeds upon exercise of warrants.
- Warrants expire August 30, 2029, unless exercised earlier.

## SEC filing metadata
- accession: 0001367644-24-000158
- form_type: 8-K
- ticker: EBS
- cik: 0001367644
- company_name: Emergent BioSolutions Inc.
- filed_at: 2024-09-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000158/0001367644-24-000158-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1367644/000136764424000158/ebs-20240917.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001367644-24-000158
- JSON: https://secwatch.observer/filing/0001367644-24-000158.json
- Plain text: https://secwatch.observer/filing/0001367644-24-000158.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.